See the DrugPatentWatch profile for Evomela
What side effects are associated with Evomela (melphalan) ?
Evomela (melphalan) can cause side effects typical of chemotherapy, with the most important risks involving bone-marrow suppression (low blood counts) and infection. Commonly reported effects with melphalan-based regimens include nausea and vomiting and low blood cell counts, which can lead to complications like infection and bleeding risk [1].
What are the most serious Evomela side effects to watch for?
The main serious concerns with melphalan include:
- Severe low white blood cells (neutropenia), raising the risk of serious or fatal infections [1].
- Severe low platelets (thrombocytopenia), which can increase bleeding risk [1].
- Severe anemia (low red blood cells), which can cause significant fatigue and weakness [1].
Because these complications can become life-threatening quickly, patients are typically monitored closely during and after treatment [1].
What symptoms might patients experience day to day?
Patients may experience chemotherapy-like gastrointestinal effects and fatigue. Reported effects with melphalan treatments can include:
- Nausea and vomiting [1].
- Diarrhea or mucosal irritation in some patients [1].
- General weakness or tiredness due to treatment and low blood counts [1].
Who should call their clinician urgently?
Seek urgent medical care if you develop symptoms that could signal infection, bleeding, or other complications—especially fever (for infection), unusual bruising or bleeding (for low platelets), or severe shortness of breath/faintness (which can occur with low blood counts) [1].
How long do Evomela side effects last?
Side effects related to bone-marrow suppression often appear after treatment as blood counts drop and can take time to recover. Your care team usually provides specific monitoring and recovery expectations based on your regimen and transplant plan [1].
Can supportive medications reduce Evomela side effects?
Clinicians commonly use supportive care with chemotherapy to reduce complications from low blood counts and nausea, such as anti-nausea medicines and infection-prevention/monitoring strategies, depending on the patient’s situation [1].
---
Sources
[1] https://www.drugs.com/evomela.html